SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Somatogen (SMTG)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (366)2/2/1998 1:41:00 PM
From: biowa  Read Replies (1) of 442
 
V1,

Very interesting press release from Biopure. Two questions from that though:

1) They say that no one can compete with them on a cost or availability basis, are they taking into account SMTG? BTW, has SMTG ever looked at the vet mkt (might be more productive than hematopoesis trials)?

2) They keep saying that Hemapure, the human candidate is in "advanced clinical trials." Do you know, is that PII or PIII?

biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News